Trends in 5-year survival rates among breast cancer patients by hormone receptor status and stage

Overview of attention for article published in Breast Cancer Research and Treatment, August 2014

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 76 Dimensions

Readers on

mendeley: 107 Mendeley

Summary X Dimensions citations

So far, Dimensions has found 76 publications that cite this research output.

76

The most recent citing publications are shown below. View all 76 publications that cite this research output on Dimensions.

The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turkish oncology group (TOG) study

Article in International Journal of Clinical Oncology (February 2024)

Trends in the Incidence and Survival of Women with Hormone Receptor-Positive Breast Cancer from 1990–2019: A Large Population-Based Analysis

Preprint in Research Square (November 2023)

Resource‐appropriate evidence‐based strategies to improve breast cancer outcomes in low‐ and middle‐income countries guided by the Breast Health Global Initiative and Global Breast Cancer Initiative

Article in Journal of Surgical Oncology (October 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.